On the other hand, it was reported that elevated serum YKL-40 levels are associated with poor prognostic outcomes of various cancers [15] and with disease activity in rheumatoid arthritis (RA), psoriatic arthritis, and inflammatory bowel diseases [16–18]. Here, CHI3L1 is linked to cancer.